Biggest News Aggregation in the World
๐Ÿ“ฐ Current Reports News

Page 29 - Current Reports News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Current Reports. Real-time updates on events, politics, business and more.

23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024

23ME-01473, antibody targeting ULBP6: Data will be presented on the discovery and biology of ULBP6, and the potential to restore natural killer and T cell-mediated anti-tumor immunity by targeting...
San Diego United States Exchange Commission Clinical Research American Association For Cancer Research Securities Exchange

MIND Technology Announces Deferral of Preferred Stock Dividend

MIND Technology, Inc. ("MIND" or the "Company") announced today that the Company's Board of Directors (the "Board") has elected not to declare a quarterly cash dividend on its 9.00% Series A Cumulative Preferred Stock ("Series A Preferred Stock")...
United States United Kingdom Ken Dennard Zach Vaughan Rob Capps Company Nasdaq Technology Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

European Commission Expands Approval of Bristol Myers Squibb's Reblozyl® (luspatercept) to Include First-Line Treatment of Transfusion-Dependent Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (LR-MDS) -April 02, 2024 at 08:09 pm EDT

Approval of Reblozyl is based on head-to-head, pivotal Phase 3 COMMANDS study, in which Reblozyl nearly doubled the percentage of patients achieving transfusion independence and hemoglobin increase,...
United Kingdom United States Bristol Myers Squibb Monica Shaw Leukemia Unit At Humanitas Cancer Center Acceleron Pharma Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science